Drug intelligence / Profile preview

diclofenac sodium + paracetamol

Development stage
Unknown
Lead developer
Scotmann Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Pain Aid Plus is a combination analgesic product developed and marketed by Scotmann Pharmaceuticals. It contains two active ingredients: diclofenac sodium and paracetamol (acetaminophen). Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID) that functions by inhibiting the cyclooxygenase enzymes COX-1 and COX-2, thereby reducing the production of prostaglandins that mediate pain, fever, and inflammation. Paracetamol acts as a complementary analgesic and antipyretic, primarily through central nervous system pathways. This combination is indicated for the relief of acute pain and the management of chronic inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is typically administered orally in tablet form.

Brand names
Pain Aid Plus
Other names
Pain Aid PlusDiclofenac sodium and paracetamol
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac sodium + paracetamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac sodium + paracetamol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call